The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them. [electronic resource]
Producer: 20070604Description: 313-8 p. digitalISSN:- 1471-4892
- Accidental Falls -- prevention & control
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Bone Density -- drug effects
- Bone Density Conservation Agents -- pharmacology
- Bone Regeneration -- drug effects
- Bone Resorption -- prevention & control
- Cathepsin K
- Cathepsins -- pharmacology
- Denosumab
- Diphosphonates -- pharmacology
- Exercise Therapy
- Fractures, Bone -- etiology
- Humans
- Osteoporosis -- complications
- RANK Ligand
- Teriparatide -- pharmacology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.